|
|
Experience of Professor Tang Xudong in treating chronic lymphocytic leukemia based on the principle of “attacking toxin and resolving hard mass, strengthening and consolidating body resistance” |
LIU Jian1 LI Rui1 MAO Yue1 JIN Nan1 JIANG Peizhen2 TANG Xudong2 |
1.Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China;
2.Department of Hematology, Xiyuan Hospital, China Academy of Chinese Traditional Sciences, Beijing 100091, China |
|
|
Abstract Chronic lymphocytic leukemia is a type of chronic B cell lymphoproliferative disease, which is more common in the elderly. In recent years, the incidence of chronic lymphocytic leukemia is increasing, and many patients simply use western medicine chemotherapy, its effect is not ideal, and side effects happen a lot, high recurrence rate and mortality. Professor Tang Xudong is good at diagnosis and treatment of chronic lymphocytic leukemia from the perspective of integrated traditional Chinese and western medicine, the effect is remarkable, quite experienced. Professor Tang mostly treats chronic lymphocytic leukemia from the treatment idea of “attacking toxin and resolving hard mass, strengthening and consolidating body resistance”. In the early stage, “attacking toxin and resolving hard mass” is used as the method to break blood and remove blood stasis, disinfect and resolve hard mass, and remove pathogenic qi. In the middle stage, the method of “strengthening and consolidating body resistance” is used to consolidat body resistance and strengthen vital qi, help the pathogenic qi go out. In the later stage, “benefiting qi and nourishing yin” is the main method, benefiting qi and consolidating body resistance, nourishing yin, and promoting fluid production, and replenishing the vital qi of the body damaged by diseases. Professor Tang to “attacking toxin and resolving hard mass, strengthening and consolidating body resistance” for treating chronic lymphocytic leukemia, in the treatment of before, during, and after use of traditional Chinese medicine treatment, at the same time of removing pathogenic qi, take care of the vital qi of the injured human body and treat and use the medicine flexibly according to the clinical symptoms and related syndrome of the patients, which has achieved good results, which is worth learning and reference.
|
|
|
|
|
[1] 李建勇,夏奕,徐卫.新药时代慢性淋巴细胞白血病的治疗选择[J].山东大学学报(医学版),2019,57(7):21- 30.
[2] 中华医学会血液学分会,中国抗癌协会血液肿瘤专业委员会.中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断与治疗指南(2015年版)[J].中华血液学杂志,2015, 36(10):809-813.
[3] 陈宝安.血液肿瘤药物研究的新征途与展望[J].药学进展,2022,46(6):401-402.
[4] 赵东陆,马军.慢性淋巴细胞白血病一线治疗研究进展[J].内科理论与实践,2020,15(5):290-294.
[5] 程诗佳,马红霞,王羽.慢性淋巴细胞白血病治疗进展[J].白血病·淋巴瘤,2020,29(6):381-384.
[6] Fischer K,Bahlo J,Fink AM,et al. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL:updated results of the CLL8 trial [J]. Blood,2016,127(2):208-215.
[7] 刘夫红,薛松,张永平,等.11例白血病异基因造血干细胞移植后复发行二次移植的临床研究[J].临床血液学杂志,2021,34(3):171-176.
[8] 赵国珍.扶正祛邪平衡法联合苯丁酸氮芥治疗老年性慢性淋巴细胞白血病的临床研究.[J]中医临床研究,2021, 13(29):62-65.
[9] 李琼谦,张炜华.通积散联合化疗治疗慢性淋巴细胞白血病的疗效观察.[J]中国医药指南,2017,15(14):185- 186.
[10] 葛志红,李达.血液病专病中医临床诊治[M].北京:人民卫生出版社,2013:283-284.
[11] 缪扣荣,徐卫,李建勇.慢性淋巴细胞白血病的诊断与治疗[J].内科急危重症杂志,2011,17(5):260-261, 281.
[12] 粱冰,葛志红.血液科专病中医临床诊治[M].北京:人民卫生出版社,2000:277.
[13] 刘义祥,巫和蓉.慢性淋巴细胞白血病证治体会[J].河南中医,2001,21(2):40-41.
[14] 单渊东.慢性淋巴细胞白血病的治疗现状[J].北京医学,2003,25(1):55-58.
[15] 姚尔固.慢性淋巴细胞白血病的治疗进展[J].中国实用内科杂志,2001,21(6):325-327.
[16] 林双,梁冰,代喜平.梁冰教授治疗慢性淋巴细胞白血病临床经验[J].四川中医,2016,35(2):8-10.
[17] 魏孝艾,朱婷婷,陈雷.慢性淋巴细胞白血病临床特征及预后分析探索[J].系统医学,2020,5(2):123-125.
[18] 许亚梅,贾玫,张雅月,等.恶性淋巴瘤(石疽)常见证候要素及中医证型初探[J].北京中医药,2012,31(10):727- 729.
[19] Steven HS,Elias C,Stefano AP,et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J]. Blood,2016 (127):2375-2390.
[20] 李雅竹,许亚梅.消癥散结法治疗慢性淋巴细胞白血病1例[J].北京中医药,2020,39(1):90-92.
[21] 张莳,唐家宏,王海涛.益气养阴补血活血方联合西药治疗慢性淋巴细胞白血病疗效分析[J].中国疗养医学,2020,29(7):780-782.
[22] 朱征,史哲新.益气养阴解毒法治疗老年微小残留白血病验案1则[J].中医临床研究,2018,10(31):59-60.
[23] 李玲,易雪.益气养阴补血活血法配合西药治疗慢性淋巴细胞白血病疗效观察[J].湖北中医杂志,2018,40(4):14-16.
[24] 李晓蕾,吴迪炯,李杭超,等.周郁鸿分期论治慢性淋巴细胞白血病经验[J].上海中医药杂志,2019,53(11):34- 36.
[25] 王金环,闫津豪,孙伟正.孙伟正教授诊疗慢性淋巴细胞白血病经验[J].时珍国医国药,2021,32(1):200- 201.
[26] 苏浩杰,刘巧萍,李达.李达基于“固本澄源法”和血论治慢性白血病经验初探.[J]中医药临床杂志,2021,33(9):1673-1676. |
|
|
|